Dockendorff Charles J

Average Profitability
18.95%
Insider Buys Quantity
3
Insider Buys Sum
$2.5M
Insider Sells Quantity
7
Insider Sells Sum
$5.56M

Insider Activity of Dockendorff Charles J

According to the SEC Form 4 filings, Dockendorff Charles J, being in a position of

  1. director at Boston Scientific Corporation,
    оver the last 12 months, has bought 0 shares, and sold 3946 shares for $286,874,
    over all time since 2016-02-12, has bought 30000 shares for $494,688, and sold 21025 shares for $1.15M.

The largest purchase of all time was on 2018-03-15 and amounted to 26000 shares of Hologic, Inc. for $1.01M.

The largest sale of all time was on 2021-02-04 and amounted to 12180 shares of Haemonetics Corporation for $1.64M.

Biography of Dockendorff Charles J

No biography is available at this moment.

2024-05-07SaleBoston Scientific Corporation
BSX
director
3,946
0.0003%
$72.70$286,874+7.24%
2024-03-08SaleHologic, Inc.
HOLX
director
1,465
0.0006%
$76.21$111,648+0.96%
2024-01-02SaleHologic, Inc.
HOLX
director
16,017
0.0067%
$72.00$1.15M+5.4%
2023-09-05SaleHaemonetics Corporation
HAE
director
10,215
0.0202%
$87.68$895,651-2.33%
2023-08-18SaleBoston Scientific Corporation
BSX
director
17,079
0.0012%
$50.74$866,631+28.76%
2022-12-13SaleKeysight Technologies, Inc.
KEYS
director
3,257
0.0018%
$185.06$602,753-15.37%
2021-02-04SaleHaemonetics Corporation
HAE
director
12,180
0.024%
$134.53$1.64M-53.37%
2018-03-15PurchaseHologic, Inc.
HOLX
director
26,000
0.0095%
$38.80$1.01M+5.07%
2017-06-09PurchaseKeysight Technologies, Inc.
KEYS
director
26,420
0.0143%
$37.81$998,940+16.39%
2016-02-12PurchaseBoston Scientific Corporation
BSX
director
30,000
0.0022%
$16.49$494,688+35.4%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.